Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) CEO John E. Kao sold 90,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The shares were sold at an average price of $11.33, for a total value of $1,019,700.00. Following the completion of the sale, the chief executive officer now owns 2,543,100 shares of the company’s stock, valued at $28,813,323. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Alignment Healthcare Stock Up 1.2 %
ALHC stock opened at $11.45 on Friday. The business has a 50-day moving average of $10.03 and a 200-day moving average of $8.13. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $12.36. The stock has a market capitalization of $2.19 billion, a P/E ratio of -13.96 and a beta of 1.47. The company has a debt-to-equity ratio of 1.70, a current ratio of 1.61 and a quick ratio of 1.61.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. Alignment Healthcare had a negative return on equity of 101.10% and a negative net margin of 6.85%. The firm had revenue of $681.29 million during the quarter, compared to the consensus estimate of $637.66 million. During the same quarter in the prior year, the firm posted ($0.15) EPS. The business’s revenue was up 47.3% on a year-over-year basis. On average, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Alignment Healthcare
Analyst Upgrades and Downgrades
A number of analysts have recently commented on ALHC shares. Piper Sandler reaffirmed an “overweight” rating and issued a $10.00 price target (up from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. Robert W. Baird upped their target price on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research note on Wednesday, August 14th. Barclays lifted their price target on shares of Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Finally, KeyCorp assumed coverage on Alignment Healthcare in a research note on Friday. They set a “sector weight” rating on the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $9.83.
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Recommended Stories
- Five stocks we like better than Alignment Healthcare
- What is the Shanghai Stock Exchange Composite Index?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- What Are the FAANG Stocks and Are They Good Investments?
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.